Literature DB >> 22548737

Visualization of blood drainage area from hypervascular hepatocellular carcinoma on ultrasonographic images during hepatic arteriogram: Comparison with depiction of drainage area on contrast-enhanced ultrasound.

Ryuichi Kita1, Azusa Sakamoto, Yoshiaki Nagata, Norihiro Nishijima, Atsuyuki Ikeda, Hiroo Matsuo, Mitsumasa Okada, Shinji Ashida, Toshikatsu Taniguchi, Toru Kimura, Yukio Osaki.   

Abstract

AIM: Corona enhancement is the visualized drainage area from a hypervascular tumor observed on single-level dynamic computed tomography during hepatic arteriography (CTHA) and is thought to be a high-risk area for micrometastases. However, because it cannot be visualized with ordinary ultrasonography (US), we aimed to visualize corona enhancement on US by means of arterial injection of the contrast material and to measure its thickness.
METHOD: Forty-one hypervascular hepatocellular carcinoma (HCC) cases were prospectively investigated. US during hepatic arteriography (USHA) was executed by means of selective injection of the contrast material perfluorobutane (Sonazoid) from the hepatic artery. Ordinary contrast-enhanced US with venous administration of contrast material and single-level dynamic CTHA were also performed.
RESULTS: Corona enhancement was observed in 36 cases (88%) on USHA and in 25 cases (61%) on single-level dynamic CTHA. The thickness of corona enhancement of 36 cases visualized with USHA ranged 3.1-18.4 mm and the mean thickness ± standard deviation was 6.0 ± 3.0 mm. Thickness of corona enhancement was less than 10.0 mm in 34 cases (94%).
CONCLUSION: Corona enhancement could be visualized even on US images, and the average thickness of them was 6 mm.
© 2012 The Japan Society of Hepatology.

Entities:  

Year:  2012        PMID: 22548737     DOI: 10.1111/j.1872-034X.2012.01019.x

Source DB:  PubMed          Journal:  Hepatol Res        ISSN: 1386-6346            Impact factor:   4.288


  8 in total

1.  Hemodynamic changes during balloon-occluded transarterial chemoembolization (B-TACE) of hepatocellular carcinoma observed by contrast-enhanced ultrasound.

Authors:  Katsutoshi Sugimoto; Toru Saguchi; Kazuhiro Saito; Yasuharu Imai; Fuminori Moriyasu
Journal:  J Med Ultrason (2001)       Date:  2013-08-29       Impact factor: 1.314

2.  Early hemodynamics of hepatocellular carcinoma using contrast-enhanced ultrasound with Sonazoid: focus on the pure arterial and early portal phases.

Authors:  Akiko Saito; Masakazu Yamamoto; Satoshi Katagiri; Shingo Yamashita; Masayuki Nakano; Toshio Morizane
Journal:  Glob Health Med       Date:  2020-10-31

Review 3.  Hepatocellular Carcinoma: Current Imaging Modalities for Diagnosis and Prognosis.

Authors:  Maxime Ronot; Yvonne Purcell; Valérie Vilgrain
Journal:  Dig Dis Sci       Date:  2019-04       Impact factor: 3.199

4.  Contrast-enhanced ultrasonography evaluation of hepatocellular carcinoma with peritumoral fat-spared area: a case report.

Authors:  Atsuyuki Ikeda; Yoko Oiwa; Hiroyuki Kokuryu
Journal:  J Med Ultrason (2001)       Date:  2017-09-12       Impact factor: 1.314

Review 5.  CT and MR imaging diagnosis and staging of hepatocellular carcinoma: part II. Extracellular agents, hepatobiliary agents, and ancillary imaging features.

Authors:  Jin-Young Choi; Jeong-Min Lee; Claude B Sirlin
Journal:  Radiology       Date:  2014-10       Impact factor: 11.105

Review 6.  Role of contrast-enhanced ultrasonography with Sonazoid for hepatocellular carcinoma: evidence from a 10-year experience.

Authors:  Hitoshi Maruyama; Tadashi Sekimoto; Osamu Yokosuka
Journal:  J Gastroenterol       Date:  2015-12-22       Impact factor: 6.772

Review 7.  Tumor Hemodynamics and Hepatocarcinogenesis: Radio-Pathological Correlations and Outcomes of Carcinogenic Hepatocyte Nodules.

Authors:  Kazuhiko Ueda; Osamu Matsui; Azusa Kitao; Satoshi Kobayashi; Jun Nakayama; Shinich Miyagawa; Masumi Kadoya
Journal:  ISRN Hepatol       Date:  2014-03-03

8.  Intraarterial contrast-enhanced ultrasound to predict the short-term tumour response of hepatocellular carcinoma to Transarterial chemoembolization with Lipiodol.

Authors:  Jiang Bo; Han Peng; Zhu LianHua; Fei Xiang; Luo YuKun
Journal:  BMC Cancer       Date:  2021-11-02       Impact factor: 4.430

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.